Researchers from the Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute have published the sequential surveillance findings for ten prespecified safety outcomes of exposure to RSVpreF during pregnancy over the course of its first vaccination season in the US. More information is available here. Photo by www.kaboompics.com
» Read more
ENTIS member Laure Sillis will defend her PhD thesis “Real-World Data to Evaluate Medication Safety in Pregnancy” on Thursday, June 4th 2026 at 17:00 (CET) in Leuven, Belgium. The defence will also be accessible via livestream. The thesis explores how different real-world data sources – from self-reported pregnancy registry data to large-scale administrative healthcare databases – can be used to […]
» Read more
ENTIS and Lareb (the local organizing committee of this years conference) are delighted to share some exciting news—the programme for the 2026 ENTIS meeting has now been published! You can find all the information about sessions and topics here. Keep an eye out, as details about the oral presenters will be added soon too. If you are planning to attend […]
» Read more
Researchers from the University of Bergen have published a systematic review demonstrating the conflicting nature of the evidence surrounding the risk of neurodevelopmental disorders following in utero topiramate exposure. More information is available here.
» Read more
ENTIS associate members PhD candidate Laure Sillis and Dr Michael Ceulemans, alongside colleagues from KU Leuven, have published a study comparing self-reported maternal health and mother-infant outcomes in the BELpREG registry with medical record data from gynaecologists, general practitioners, and midwives. More information is available here.
» Read more
ENTIS associate members PhD candidate Laure Sillis, Dr Essi Whaites Heinonen and Dr Michael Ceulemans, alongside OTIS colleagues from University of California San Diego La Jolla (California, USA), have published a study using the MotherToBaby cohort investigating the risk for adverse birth outcomes following maternal use of medicines for nausea and vomiting in pregnancy. More information is available here.
» Read more
ENTIS associate members PhD candidate Laure Sillis and Dr Michael Ceulemans, alongside colleagues from KU Leuven, have published an updated summary of the medication, vaccine and folic acid use data from the the BELpREG Cohort. More information is available here.
» Read more
Researchers from the Division of Pharmacoepidemiology and Pharmacoeconomics at the Brigham and Women’s Hospital in Boston, USA, have published a study utilising a tree-based scan statistic (TBSS) approach evaluating the risk of a range of specific malformations and malformation groupings and their association with prenatal antipsychotic exposure. More information is available here. Photo by Pankaj Patel on Unsplash
» Read more
Researchers from the ENTIS member organisation Netherlands Pharmacovigilance Centre Lareb have published a comparative cohort study using the Dutch Pregnancy Drug Register to assess the risk of adverse neonatal outcomes following maternal pertussis vaccination in pregnancy. More information is available here. Photo by Alexander Grey on Unsplash
» Read more
An international collaboration of teratology researchers, several of whom are affiliated with ENTIS, have published an up-to-date meta-analysis exploring major congenital malformation risks following paternal exposure during spermatogenesis. More information is available here. Photo by Daniel Kraus on Unsplash
» Read more